Anthony Rosenberg
Head, Partnering & Emerging Businesses, Novartis Pharma
Anthony Rosenberg is Head of Partnering & Emerging Businesses and a member of the Pharma Executive Committee. He joined Sandoz in 1980 in the U.K. where he held various leadership positions in sales and marketing, business development, and strategic planning. In 1994 he moved to Basel, initially as International Product Manager (Clozaril), and undertook roles of increasing responsibility in Global Marketing, ultimately as Head Global Marketing Primary Care.
In 2000 he became Global Head of the Transplant and Immunology Business Unit. In 2005 he was appointed Global Head Business Development & Licensing and has managed over 30 major inlicensing transactions in the cardiovascular, CNS, respiratory, infectious disease and oncology areas. In 2010 he was given additional responsibility for leadership of the Molecular Diagnostics group. He is a member of the Board of Directors of Idenix and the Novartis Venture Option Fund. Tony Rosenberg has a BSc (Biological Sciences) University of
Leicester, and an MSc (Physiology) University of London.